Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation
Markus Löffler, Daniel J. Kowalewski, Linus Backert, et al.
Cancer Research (2018) Vol. 78, Iss. 16, pp. 4627-4641
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction
Jennifer G. Abelin, Dewi Harjanto, Matthew Malloy, et al.
Immunity (2019) Vol. 51, Iss. 4, pp. 766-779.e17
Open Access | Times Cited: 218
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Sebastian P. Haen, Markus Löffler, Hans‐Georg Rammensee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 595-610
Open Access | Times Cited: 172
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
Alice Newey, B Griffiths, Justine Michaux, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 126
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus Löffler, Christopher Mohr, Leon Bichmann, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 121
The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
Anastasia Mpakali, Efstratios Stratikos
Cancers (2021) Vol. 13, Iss. 1, pp. 134-134
Open Access | Times Cited: 89
Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition
Lauren Stopfer, Joshua M. Mesfin, Brian A. Joughin, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion
Hatem Tallima, Hassan Mohamed El-Said Azzazy, Rashika El Ridi
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 58
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
Jan Dörrie, Niels Schaft, Gerold Schuler, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 92-92
Open Access | Times Cited: 61
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Hans-Georg Rammensee, Karl-Heinz Wiesmüller, P. Anoop Chandran, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 57
Single-cell derived tumor organoids display diversity in HLA class I peptide presentation
Laura C. Demmers, Kai Kretzschmar, Arne van Hoeck, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 52
Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples
Susan Klaeger, Annie Apffel, Karl R. Clauser, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100133-100133
Open Access | Times Cited: 46
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines
Sara Feola, Jacopo Chiaro, Beatriz Martins, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 32
The Origin and Immune Recognition of Tumor-Specific Antigens
Anca Apavaloaei, Marie‐Pierre Hardy, Pierre Thibault, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2607-2607
Open Access | Times Cited: 48
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process
Sara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1660-1660
Open Access | Times Cited: 47
Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability
Jenna Cleyle, Marie‐Pierre Hardy, Robin Minati, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 5, pp. 100228-100228
Open Access | Times Cited: 27
Integrating immunopeptidome analysis for the design and development of cancer vaccines
Sara Feola, Jacopo Chiaro, Vincenzo Cerullo
Seminars in Immunology (2023) Vol. 67, pp. 101750-101750
Open Access | Times Cited: 13
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
Markus Löffler, Bianca Nussbaum, Günter Jäger, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 36
Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation
Rachel Marty Pyke, Dattatreya Mellacheruvu, Steven Dea, et al.
Molecular & Cellular Proteomics (2021) Vol. 20, pp. 100111-100111
Open Access | Times Cited: 30
Advances in immunotherapy for MMR proficient colorectal cancer
Hazel Lote, Naureen Starling, Rille Pihlak, et al.
Cancer Treatment Reviews (2022) Vol. 111, pp. 102480-102480
Open Access | Times Cited: 21
The Immunopeptidomic Landscape of Ependymomas Provides Actionable Antigens for T Cell-Based Immunotherapy
Lena Mühlenbruch, David Rieger, Hannes Becker, et al.
Neuro-Oncology Advances (2025)
Open Access
IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT
Rui Chen, Kelly M. Fulton, Susan M. Twine, et al.
Mass Spectrometry Reviews (2019) Vol. 40, Iss. 2, pp. 110-125
Closed Access | Times Cited: 31
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies
Martin G. Klatt, Tao Dao, Zhiyuan Yang, et al.
Blood (2022) Vol. 140, Iss. 8, pp. 861-874
Open Access | Times Cited: 17
Oxidized Melanoma Antigens Promote Activation and Proliferation of Cytotoxic T‐Cell Subpopulations
Ramona Clemen, Lea Miebach, Debora Singer, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 3
Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome
Laura Santambrogio, Hans-Georg Rammensee
Immunogenetics (2018) Vol. 71, Iss. 3, pp. 203-216
Open Access | Times Cited: 31
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification
Sara Feola, Markus Haapala, Karita Peltonen, et al.
ACS Nano (2021) Vol. 15, Iss. 10, pp. 15992-16010
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top